Impax Asset Management Group plc Reduces Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Impax Asset Management Group plc decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 89.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 198,249 shares of the medical device company's stock after selling 1,766,500 shares during the period. Impax Asset Management Group plc owned 0.10% of Cooper Companies worth $16,542,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of COO. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cooper Companies by 15.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after acquiring an additional 3,440 shares in the last quarter. State of Alaska Department of Revenue increased its position in shares of Cooper Companies by 3.0% in the 1st quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock valued at $1,972,000 after acquiring an additional 680 shares during the period. Proficio Capital Partners LLC acquired a new stake in Cooper Companies during the 4th quarter worth about $95,000. Steward Partners Investment Advisory LLC increased its holdings in shares of Cooper Companies by 19.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company's stock valued at $129,000 after purchasing an additional 226 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in shares of Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock worth $2,211,000 after purchasing an additional 312 shares during the period. Institutional investors own 24.39% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on COO shares. UBS Group raised shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Wells Fargo & Company reduced their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research note on Friday, May 30th. Loop Capital set a $100.00 target price on Cooper Companies in a research note on Tuesday, June 17th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $99.70.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $0.01 during mid-day trading on Monday, reaching $73.29. The company's stock had a trading volume of 3,553,227 shares, compared to its average volume of 1,719,710. The stock has a 50-day moving average of $75.62 and a two-hundred day moving average of $83.20. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The stock has a market capitalization of $14.66 billion, a P/E ratio of 35.58, a P/E/G ratio of 1.79 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.85 earnings per share. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.